Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Purple Biotech (PPBT) Return on Capital Employed (2016 - 2025)

Purple Biotech has reported Return on Capital Employed over the past 3 years, most recently at 13.33% for Q4 2022.

  • Quarterly Return on Capital Employed fell 1318.0% to 13.33% in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 13.33% through Dec 2022, down 1318.0% year-over-year, with the annual reading at 11.93% for FY2022, 3658.0% up from the prior year.
  • Return on Capital Employed was 13.33% for Q4 2022 at Purple Biotech, down from 38.26% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 38.26% in Q3 2022 and troughed at 13.33% in Q4 2022.
  • The 3-year median for Return on Capital Employed is 29.08% (2021), against an average of 28.23%.
  • The largest YoY upside for Return on Capital Employed was 829bps in 2022 against a maximum downside of -1318bps in 2022.
  • A 3-year view of Return on Capital Employed shows it stood at 25.97% in 2020, then increased by 2bps to 26.5% in 2021, then crashed by -50bps to 13.33% in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Return on Capital Employed are 13.33% (Q4 2022), 38.26% (Q3 2022), and 31.9% (Q2 2022).